Dashboard

AbbVie, Inc. (ABBV)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

B

Industry Comparison

H

Management & Equity

B

Analyst Opinion

S

Leverage & Liquidity

S

Fundamental Variables

H

Rating Performance

FV Performance

About

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

CEO

Richard A. Gonzalez

Employees

30,000

Industry

Diversified Biopharmaceuticals

Sector

Healthcare

Headquarters

North Chicago

Exchange

New York Stock Exchange

Summary Stats

Market Cap

266B

Revenue

56.7B

Net Income

12.4B

EPS

$6.98

Price-to-Earnings

21.57

Price-to-Book

16.34

Debt-to-Equity

7.8

News

Analyst Ratings

Price targets projected by 20 analysts

High

$127.00

Average

$111.45

Low

$97.00

Ratings calculated by 22 analysts

Buy

16

Hold

6

Sell

0

Last Dividend

Amount

$1.41

Dividend Date

Frequency

quarterly

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q1 2022

Last Earnings

Above by $0.02

Actual

$3.16 +0.6%

Consensus

3.14

Report Date

Year Ago

2.95

Year Ago Change %

Up 7%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites